is semaglutide fda approved for obesity Wegovy® – A New Treatment Novo Nordisk's Wegovy® pill (oral
Description
Obesity affects over a third of adults, fueling diabetes and heart disease
Un pisode pour mieux comprendre, mieux accompagner et mieux traiter
It is not a drug, food, or cosmetic and is not for human or animal consumption
EGD was performed showing a large amount of food in the stomach but no gastric outlet obstruction with ability to visualize the jejunum
Prior research has shown that it triggers apoptosis in endometrial cancer cells
#Pharma #FDAApproval #Wegovy #NovoNordisk #GLP1 #ObesityDrug #BuchPharma #PharmaNews #WeightLoss #HealthcareInnovation
